Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love AxoGen, Inc. (AXGN)?

Page 1 of 2

Before we spend days researching a stock idea we’d like to take a look at how hedge funds and billionaire investors recently traded that stock. S&P 500 Index returned about 5.2% during the last 12 months ending October 30, 2015. Less than 49% of the stocks in the index outperformed the index. This means you (or a monkey throwing a dart) have less than an even chance of beating the market by randomly picking a stock. On the other hand, the top 30 S&P 500 stocks among hedge funds at the end of September 2014 had an average return of 9.5% during the same period. Sixty three percent of these 30 stocks outperformed the market. Hedge funds had bad stock picks like everyone else. Micron, which lost 50% over this period, was one of hedge funds’ 30 favorite S&P 500 stocks. Anadarko Petroleum was another failed stock pick which lost more than 26%. So, taking cues from hedge funds isn’t a foolproof strategy, but it seems to work on average. In this article, we will take a look at what hedge funds think about AxoGen, Inc. (NASDAQ:AXGN).

AxoGen, Inc. (NASDAQ:AXGN)’s shares surged by more than 30% in the third quarter, and experienced a slight increase in hedge fund sentiment although the stock remains overlooked by most investors that we track. AXGN was in 4 hedge funds’ portfolios at the end of the third quarter of 2015. At the end of this article we will also compare AXGN to other stocks including Intevac, Inc. (NASDAQ:IVAC), SCYNEXIS Inc (NASDAQ:SCYX), and Lakeland Industries, Inc. (NASDAQ:LAKE) to get a better sense of its popularity.

Follow Axogen Inc. (NASDAQ:AXGN)
Trade (NASDAQ:AXGN) Now!

In the 21st century investor’s toolkit there are plenty of indicators stock traders have at their disposal to size up their holdings. A duo of the most under-the-radar indicators are hedge fund and insider trading sentiment. Our researchers have shown that, historically, those who follow the top picks of the best hedge fund managers can beat the broader indices by a significant amount (see the details here).

With all of this in mind, let’s go over the key action regarding AxoGen, Inc. (NASDAQ:AXGN).

How are hedge funds trading AxoGen, Inc. (NASDAQ:AXGN)?

Heading into Q4, a total of 4 of the hedge funds tracked by Insider Monkey were bullish on this stock, up by one over the quarter. With the smart money’s capital changing hands, there exists a few noteworthy hedge fund managers who were increasing their holdings substantially (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Deerfield Management, managed by James E. Flynn, holds the most valuable position in AxoGen, Inc. (NASDAQ:AXGN). Deerfield Management has a $13.9 million position in the stock, comprising 0.5% of its 13F portfolio. The second most bullish fund is Opaleye Management, managed by James A. Silverman, which holds a $8.7 million position; 4.3% of its 13F portfolio is allocated to the company. Remaining professional money managers that are bullish comprise Mitchell Blutt’s Consonance Capital Management and Jim Simons’ Renaissance Technologies.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!